02
Feb
2018
09:00
GMT
Webinar
Utilizing NOAC's in Non-Valvular Atrial Fibrillation Patients Undergoing PCI
-
Views:
404
-
Likes:
0
Overview
This independent medical education (IME) series has been created for English, German and Spanish speaking cardiologists and is designed to showcase the latest updates emerging from the data in novel oral anticoagulants in non-valvular atrial fibrillation patients undergoing PCI.
It will consider the latest recommendations on bleeding risks and the impact this has on the optimum duration of therapy with NOACs, for those patients with atrial fibrillation. In particular, the WOEST, PIONEER and RE-DUAL-PCI studies will be considered.
Upon completion of this activity, participants will:
- Apply knowledge gained on the complex nature of antithrombotic therapies in non-valvular AF patients undergoing PCI in a range of clinical scenarios
- Increase knowledge on the complications surrounding triple antithrombotic therapy
- Understand the latest clinical evidence regarding the use of NOAC therapy in AF patients undergoing PCI
Faculty:
Robert A Byrne
Prof Georg Nickenig
Stefan H Hohnloser
Pepe Zamorano
José López-Sendón
Key Learning Objectives
- Describe the complex nature and current recommendations for antithrombotic therapy for non-valvular AF patients undergoing PCI
- Define the complications associated with TAT
- Summarize the latest data utilizing NOAC therapy in AF patients undergoing PCI
Target Audience
This webinar is aimed at:
- Interventional cardiologists
- Electrophysiologists
- General cardiologists
Faculty Biographies
Robert A Byrne
Dr Robert A Byrne is an interventional cardiologist and Deputy Head of the Clinic for Cardiovascular Diseases, Deutsches Herzzentrum, Munich, Germany.
Dr Byrne graduated from University College Dublin and completed his PhD at the Technische Universität in Munich, Germany.
Dr Byrne's research awards include the ESC Atherothrombosis Research Fellowship (2008), the TCT Thomas J. Linnemeier Young Investigator Award (2009) and the Andreas Grüntzig Research Prize of the German Cardiac Society (2016). His main research interests include antithrombotic therapy, DES development, drug-coated balloon therapy, OCT imaging, coronary restenosis and stent thrombosis, and medical device regulatory affairs.
He is principal investigator or steering committee member in several clinical trials. Dr Byrne is a deputy editor at EuroIntervention, a board member of EAPCI and member of the ESC Regulatory Affairs and Congress Programme Committees.
Prof Georg Nickenig
Dr Georg Nickenig is a Full Professor and Chair, Department of Internal Medicine and Polyclinic II, University Hospital Bonn, Germany.
Dr Nickenig completed his doctoral degree in Clinical Medicine from the University of Bonn.
Stefan H Hohnloser
Stefan H Hohnloser is Professor of Medicine and Cardiology at the Johann Wolfgang Goethe University in Frankfurt, Germany, where he is the Head of the Department of Electrophysiology. His primary research interests include sudden cardiac death and its prevention by device therapy.
Pepe Zamorano
Head of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain